Real-world data (RWD) is transforming drug development by complementing traditional clinical trials with evidence from actual patient experiences. Health records, insurance claims, wearable devices, and patient registries provide insights into safety, effectiveness, and usage. This accelerates innovation, reduces costs, and supports regulatory decisions—making drug development more adaptive and patient-centered.